Department of Medicine

Department of Medicine

  Division of Rheumatology and Clinical Immunology

[Return To Index page]
photo Robyn T. Domsic, MD, MPH

Associate Professor of Medicine


Phone: 412-383-8000

Office: S724 Biomedical Science Tower
3500 Terrace Street
Pittsburgh, PA 15261
Phone: 412-383-8000
Fax: 412-383-8753
Administrative Assistant:
Linda Sadej
Address: 3500 Terrace Street
BST-South, 7th floor
Pittsburgh, PA 15261
Education and Training
BS, University of Iowa, 1996
M.D., University of Iowa Carver College of Medicine, 2001
M.P.H., University of Pittsburgh, 2008
Internship, Duke University Medical Center, 2002
Residency, Duke University Medical Center, 2004
Fellowship, University of Pittsburgh Medical Center, 2006
Research Interest
Dr. Domsic's research interest centers around improving the care of patients with scleroderma. Her research to date has focused on creating and testing risk stratification strategies for scleroderma patients. These tools can be used to improve both patient care and clinical trial design. Her second main area of research interest is Raynaud's phenomenon and the vascular manifestations of scleroderma. Specifically she is interested in novel imaging techniques for vascular involvement in scleroderma and assessing new outcome measures for testing therapies treating Raynaud's phenomenon.

Dr. Domsic continues to be actively involved in several multi-center clinical trials investigating potential therapies for the management of scleroderma and Raynaud's phenomenon. Recently, she was awarded funding for an investigator-initiated trial examining the effect of atorvastatin on Raynaud's phenomenon that will be completed only at the University of Pittsburgh.
Clinical Interest
Dr. Domsic's primary clinical focus is the evaluation, management and care of
patients with all types of scleroderma. She is the Clinical Director and sees patients in the Scleroderma Center, which is a multidisciplinary center dedicated to patient care and research of scleroderma.

Dr. Domsic is also interested in the evaluation and management of patients with
Raynaud phenomenon and mixed connective tissue disease.
For my complete bibliography, Click Here.
Selected Publications:
SW Zivkovic, W Freiberg, D Lacomis, RT Domsic, TA Medsger Jr. Localized scleroderma and regional inflammatory myopathy. Neuromuscular Disorders. 2014; 24(5): 425-430.
RD Domsic, SI Nihtyanova, SR Wisniewski, MJ Fine, M Lucas, CK Kwoh, CP Denton, TA Medsger Jr. Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis. Arthritis and Rheumatology. 2014; 66(6): 1616-1624.
L Chung, RT Domsic, ..., VD Steen. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care and Research (Hoboken). 2014; 66(3): 489-495.
TM Frech, VK Shanmugam, AA Shah, ..., RT Domsic. Treatment of early diffuse systemic sclerosis skin disease. Clinical and Experimental Rheumatology. 2013; 31(2 Suppl 76): 166-171.
A Dore, M Lucas, D Ivanco, TA Medsger Jr., RT Domsic. Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis. Arthritis Care and Research (Hoboken). 2013; 65(8): 1385-1389.
V Steen, RT Domsic, M Lucas, N Fertig, TA Medsger Jr. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis and Rheumatism. 2012; 64(9): 2986-2994.
DW Koschik 2nd, N Fertig, MR Lucas, RT Domsic, TA Medsger Jr. Anti-PM-Scl antibody in patients with systemic sclerosis. Clinical and Experimental Rheumatology. 2012; 30(2 Suppl 71): S12-16.
RT Domsic, T Rodriguez-Reyna, M Lucas, N Fertig, TA Medsger Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Annals of the Rheumatic Diseases. 2011; 70(1): 104-109.
I Batal, RT Domsic, TA Medsger Jr., S Bastacky. Scleroderma renal crisis: a pathology perspective. International Journal of Rheumatology. 2010; 2010: 543704.
KS Torok, NA Baker, M Lucas, RT Domsic, R Boudreau, TA Medsger Jr. Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clinical and Experimental Rheumatology. 2010; 28(2 Suppl 58): S28-36.
Sponsored Research/Activities
Title: Addressing Critical Knowledge Gaps in Early Diffuse Scleroderma Trial Design
Role: Principal Investigator
Funding Agency: National Institute of Arthristis, Muscoskel, & Skin Disease
Grant Number: R01 AR069874
Start Year: 2017
End Year: 2020
Title: A Pilot Study to Assess the Efficacy and Safety of Riociguat vs Placebo in Scleroderma-Assocaitged Digital Ulcers
Role: Principal Investigator
Funding Agency: University of Michigan
Grant Number: RES
Start Year: 2016
End Year: 2018
Title: Rituximab for Treatment of SSc-PAH (ASC01)
Role: Principal Investigator
Funding Agency: University of California Los Angeles
Grant Number: UM1 AI110498
Start Year: 2015
End Year: 2017